Examining Pregnant Women’s Attitudes Toward a Zika Vaccine Trial

From the Infectious Disease Advisor
March 4, 2019

When surveyed about participation in a hypothetic Zika vaccine clinical trial, pregnant participants placed a high premium on clinical evidence and pregnancy-specific data, according to research results published in Vaccine.

A recent survey study collected data from pregnant and postpartum women in an effort to assess their willingness to participate in a hypothetic Zika virus vaccine trial and their motivations for participating. Information on demographics, prior exposure, and vaccine acceptance was collected. Although there have been previous studies on the willingness of pregnant women to participate in vaccine research, there is significantly less information about pregnant women’s willingness to participate specifically in Zika virus vaccine trials. Congenital Zika syndrome in a baby, caused by infection during the mother’s pregnancy, can result in life-altering anomalies, and the researchers hope that a vaccine can be used against future outbreaks.

Read more